Hemostats Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Hemostats market size was valued at USD 2825 million in 2022 and is forecast to a readjusted size of USD 4149.5 million by 2029 with a CAGR of 5.6% during review period.

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%. North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent. In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

This report is a detailed and comprehensive analysis for global Hemostats market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Hemostats market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Hemostats market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Hemostats market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Hemostats market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemostats
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Hemostats market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Ethicon
   Pfizer
   Baxter International Inc.
   C. R. Bard
   The Medicines Company
   Anika Therapeutics
   Advanced Medical Solutions
   Integra LifeSciences Corporation
   B Braun Melsungen AG
   Gelita Medical GmbH
   Equimedical
   Vascular Solutions
   Marine Polymer Technologies
   Z-Medica, LLC
   CryoLife
   BioCer Entwicklungs-GmbH.
   Biom'Up SAS

   Thrombin-Based Hemostats
   Oxidized Regenerated Cellulose Based Hemostats
   Combination Hemostats
   Gelatin Based Hemostats
   Collagen Based Hemostats

   Prehospital Treatment
   Hospital Treatment

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Hemostats Market in 2025?

The Hemostats Market is expected to benefit from growing demand in surgical procedures, an aging population, and increasing incidences of trauma and surgeries. Technological advancements and the introduction of innovative hemostatic products, such as absorbable hemostats, will also enhance market growth.

What are the weaknesses of the Hemostats Market in 2025?

The high cost of advanced hemostatic products could limit market access, especially in developing regions. Additionally, there may be concerns regarding the effectiveness of some products in specific surgeries or complications arising from improper use. Limited reimbursement policies could also hinder growth in some regions.

What opportunities exist for the Hemostats Market in 2025?

There is a significant opportunity for market expansion in emerging markets where healthcare infrastructure is rapidly improving. New product development focused on reducing side effects, improving efficacy, and addressing unmet needs in niche surgical applications could open up new avenues for growth.

What are the threats to the Hemostats Market in 2025?

The Hemostats Market may face increasing competition from alternative methods of hemostasis, such as biological agents and surgical devices. Regulatory challenges and the potential for product recalls due to safety concerns could also pose significant risks to market players.

What are the political factors affecting the Hemostats Market in 2025?

Government regulations regarding healthcare products, particularly for surgical procedures, play a significant role. The approval processes for new hemostatic products could be lengthy and complex, impacting market entry. Additionally, reimbursement policies and healthcare funding decisions will affect product affordability and accessibility.

What are the economic factors influencing the Hemostats Market in 2025?

Economic conditions, including healthcare budgets and spending, will impact the adoption of advanced hemostatic products. In developed countries, rising healthcare costs might limit the availability of premium products, while in emerging economies, economic growth may lead to increased healthcare investments and demand for cost-effective solutions.

What are the social factors driving the Hemostats Market in 2025?

The aging global population and the increasing number of surgeries and trauma cases are key social drivers. As awareness of minimally invasive and effective treatments rises, demand for advanced hemostatic products will grow. Additionally, the shift towards outpatient procedures and shorter recovery times will favor hemostat adoption.

What are the technological factors affecting the Hemostats Market in 2025?

Advancements in biotechnology, materials science, and wound care are leading to the development of more effective and specialized hemostatic products. Innovations such as bioengineered hemostats and absorbable materials will provide greater precision and safety, creating opportunities for growth in the market.

What are the environmental factors impacting the Hemostats Market in 2025?

Sustainability concerns may drive the development of eco-friendly and biodegradable hemostatic products. Manufacturers may face pressure to reduce environmental impact, particularly in terms of waste from single-use items. Regulatory requirements related to environmental standards could also influence product development and manufacturing processes.

What are the legal factors influencing the Hemostats Market in 2025?

Compliance with international and local regulations concerning medical devices is critical for market players. Legal challenges, including intellectual property disputes and product liability risks, may affect companies. Additionally, stricter regulations around product safety and efficacy testing will impact the timeline for new hemostatic product launches.

Who are the suppliers in the Hemostats Market in 2025?

Suppliers include manufacturers of raw materials such as polymers, bioengineered substances, and other biocompatible materials. Companies that produce specialized hemostatic agents, such as gelatin or collagen-based products, are key suppliers. Additionally, regulatory bodies and research organizations contribute to product development.

What are the inputs for the Hemostats Market in 2025?

Inputs consist of advanced materials, including bioabsorbable polymers, proteins, and compounds used in hemostatic agents. Research and development efforts, regulatory approvals, and production technologies are crucial inputs to ensure that products meet safety and efficacy standards. Human resources and quality control systems also play an essential role.

What are the processes involved in the Hemostats Market in 2025?

Key processes include product research and development, clinical trials, regulatory approval, manufacturing, and distribution. Post-production, there is a focus on product testing, packaging, and compliance with global standards. Marketing and education about the benefits and applications of hemostatic products are also integral processes.

Who are the customers in the Hemostats Market in 2025?

Customers range from hospitals, surgical centers, and trauma units to individual surgeons and healthcare practitioners. The market also includes distributors and suppliers who sell hemostatic products to medical facilities. Patients undergoing surgeries or trauma-related treatments are indirect customers influenced by healthcare professionals' choices.

What are the outputs in the Hemostats Market in 2025?

Outputs include finished hemostatic products such as gauze, powder, sponges, and sealants designed to control bleeding during surgeries and trauma care. These products are distributed globally to hospitals, clinics, and surgical centers. Innovations in hemostatic agents will result in more advanced and specialized solutions for different surgical needs.

How strong is the threat of new entrants in the Hemostats Market in 2025?

The threat of new entrants is moderate. While the hemostats market has high growth potential, the significant regulatory hurdles, capital investment, and technical expertise required to develop safe and effective products make entry challenging. However, advancements in biotechnology and increasing demand could attract new players over time.

How intense is the bargaining power of suppliers in the Hemostats Market in 2025?

The bargaining power of suppliers is moderate. The key raw materials for hemostatic products are relatively specialized, and there are few suppliers who provide critical components. However, larger manufacturers can negotiate favorable terms with suppliers due to their scale, reducing supplier power in certain segments of the market.

How high is the bargaining power of buyers in the Hemostats Market in 2025?

The bargaining power of buyers is moderate to high. Hospitals and healthcare providers often have significant purchasing power due to the volume of products they require. However, since hemostats are essential in surgeries and trauma care, the differentiation of products based on efficacy, safety, and technology reduces the impact of bargaining power in some cases.

How intense is the threat of substitute products in the Hemostats Market in 2025?

The threat of substitutes is moderate. Alternatives such as cauterization, sutures, or natural clotting agents are available in some cases. However, hemostatic agents are often preferred for their efficiency and ease of use, particularly in trauma and high-risk surgeries, which limits the threat of substitutes.

How competitive is the Hemostats Market in 2025?

The competition in the Hemostats Market is high. Established players with advanced technologies and large product portfolios dominate the market. However, new entrants and innovations in hemostatic agents, along with increasing demand for specialized products, are intensifying competition among companies aiming to capture market share.

What are the key raw materials required for the Hemostats Market in 2025?

Key raw materials include bioabsorbable polymers, collagen, gelatin, fibrin, cellulose, and other biocompatible materials. These materials are crucial for the development of hemostatic agents that can effectively control bleeding during surgeries and trauma treatment.

What are the main suppliers of raw materials for the Hemostats Market in 2025?

Suppliers include chemical and biotechnology companies that specialize in biocompatible materials, polymers, and proteins. Large-scale manufacturers of collagen and gelatin, as well as companies providing advanced biomaterials and research institutions focused on wound care, are key players in the supply chain.

How does the supply chain impact the Hemostats Market in 2025?

The supply chain for the Hemostats Market is critical as it ensures a steady flow of high-quality materials for manufacturing. Any disruptions in the availability of key materials or changes in regulatory requirements could delay production and impact the market's ability to meet demand. Efficient logistics and supplier relationships are essential for market stability.

What regulatory considerations affect the upstream market for Hemostats in 2025?

Strict regulatory standards are a significant consideration. Raw materials used in hemostatic products must meet safety and efficacy requirements set by health authorities such as the FDA or EMA. Any changes in these regulations, including quality standards or testing procedures, could impact material sourcing and production timelines.

How does technological innovation affect the upstream market in 2025?

Technological advancements in material science, biotechnology, and manufacturing processes are driving innovation in hemostatic products. As new, more effective raw materials and production technologies emerge, suppliers will need to adapt to these changes. Innovations such as biodegradable polymers and bioengineered proteins will further enhance product performance and market demand.

What are the key manufacturing processes in the Hemostats Market in 2025?

Key manufacturing processes include the formulation of hemostatic agents, sterilization, packaging, and quality control. The production process involves integrating bioengineered materials, such as collagen and fibrin, into hemostatic products that are safe, effective, and sterile for use in surgical procedures and trauma care.

What are the challenges faced in the midstream of the Hemostats Market in 2025?

Challenges include maintaining consistent quality and compliance with regulatory standards across large-scale production. Manufacturing processes need to ensure that the hemostatic products retain their efficacy and safety. Additionally, managing the costs of production while dealing with the complexity of specialized materials can be difficult.

How do distribution and logistics impact the Midstream of the Hemostats Market in 2025?

Distribution and logistics play a vital role in ensuring timely delivery of hemostatic products to healthcare providers. Efficient supply chains are necessary to manage the demand fluctuations across hospitals, clinics, and surgical centers. Any delays in transportation or supply chain disruptions can affect product availability and market access.

What role does product innovation play in the Midstream of the Hemostats Market in 2025?

Product innovation drives the development of new hemostatic agents with improved efficacy, reduced side effects, and faster action times. Manufacturing must adapt to incorporate new technologies, such as bioengineered materials or enhanced delivery systems, into production processes. Companies that can quickly scale up innovative products gain a competitive edge in the market.

How do regulatory requirements influence midstream activities in the Hemostats Market in 2025?

Regulatory requirements have a significant impact on midstream activities, as manufacturers must ensure that products meet safety and effectiveness standards before they reach the market. These regulations dictate the testing, validation, and approval processes that are integral to product development. Compliance with international standards is critical for maintaining market access and avoiding potential recalls.

What are the key distribution channels in the Hemostats Market in 2025?

Key distribution channels include direct sales to hospitals, clinics, and surgical centers, as well as partnerships with medical distributors and wholesalers. Online platforms and third-party suppliers are also becoming more prominent as healthcare providers seek convenient purchasing options for hemostatic products.

How do healthcare providers influence the Hemostats Market in 2025?

Healthcare providers play a critical role by determining which hemostatic products are used in surgeries and trauma care. Their preference for certain brands or types of hemostats, based on factors like efficacy, safety, and cost, directly impacts market demand. Additionally, hospitals’ procurement departments are major decision-makers in product selection.

What are the challenges in the downstream segment of the Hemostats Market in 2025?

Challenges include ensuring product availability and managing distribution logistics effectively to meet the demand in healthcare settings. Price sensitivity is another issue, especially in developing regions where the cost of hemostatic products may restrict access. There are also concerns about the proper training of medical staff to use these products effectively.

How does customer demand shape the Downstream segment of the Hemostats Market in 2025?

Customer demand is influenced by factors such as the increasing number of surgeries, an aging population, and the growing awareness of advanced hemostatic products. As more healthcare professionals recognize the benefits of effective hemostasis, demand for improved, quicker-acting products will rise, pushing suppliers to innovate and meet these expectations.

What role does competition play in the Downstream of the Hemostats Market in 2025?

Competition in the downstream market is intense as multiple manufacturers vie for market share. Companies must differentiate their products through superior performance, pricing strategies, and strong relationships with healthcare providers. The availability of alternative hemostatic solutions, like biologics or advanced surgical techniques, also influences competitive dynamics.

Chapter 1, to describe Hemostats product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hemostats, with price, sales, revenue and global market share of Hemostats from 2018 to 2023.
Chapter 3, the Hemostats competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemostats breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hemostats market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hemostats.
Chapter 14 and 15, to describe Hemostats sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Hemostats
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Hemostats Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Thrombin-Based Hemostats
       1.3.3 Oxidized Regenerated Cellulose Based Hemostats
       1.3.4 Combination Hemostats
       1.3.5 Gelatin Based Hemostats
       1.3.6 Collagen Based Hemostats
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Hemostats Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Prehospital Treatment
       1.4.3 Hospital Treatment
   1.5 Global Hemostats Market Size & Forecast
       1.5.1 Global Hemostats Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Hemostats Sales Quantity (2018-2029)
       1.5.3 Global Hemostats Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Ethicon
       2.1.1 Ethicon Details
       2.1.2 Ethicon Major Business
       2.1.3 Ethicon Hemostats Product and Services
       2.1.4 Ethicon Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Ethicon Recent Developments/Updates
   2.2 Pfizer
       2.2.1 Pfizer Details
       2.2.2 Pfizer Major Business
       2.2.3 Pfizer Hemostats Product and Services
       2.2.4 Pfizer Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Pfizer Recent Developments/Updates
   2.3 Baxter International Inc.
       2.3.1 Baxter International Inc. Details
       2.3.2 Baxter International Inc. Major Business
       2.3.3 Baxter International Inc. Hemostats Product and Services
       2.3.4 Baxter International Inc. Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Baxter International Inc. Recent Developments/Updates
   2.4 C. R. Bard
       2.4.1 C. R. Bard Details
       2.4.2 C. R. Bard Major Business
       2.4.3 C. R. Bard Hemostats Product and Services
       2.4.4 C. R. Bard Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 C. R. Bard Recent Developments/Updates
   2.5 The Medicines Company
       2.5.1 The Medicines Company Details
       2.5.2 The Medicines Company Major Business
       2.5.3 The Medicines Company Hemostats Product and Services
       2.5.4 The Medicines Company Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 The Medicines Company Recent Developments/Updates
   2.6 Anika Therapeutics
       2.6.1 Anika Therapeutics Details
       2.6.2 Anika Therapeutics Major Business
       2.6.3 Anika Therapeutics Hemostats Product and Services
       2.6.4 Anika Therapeutics Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Anika Therapeutics Recent Developments/Updates
   2.7 Advanced Medical Solutions
       2.7.1 Advanced Medical Solutions Details
       2.7.2 Advanced Medical Solutions Major Business
       2.7.3 Advanced Medical Solutions Hemostats Product and Services
       2.7.4 Advanced Medical Solutions Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Advanced Medical Solutions Recent Developments/Updates
   2.8 Integra LifeSciences Corporation
       2.8.1 Integra LifeSciences Corporation Details
       2.8.2 Integra LifeSciences Corporation Major Business
       2.8.3 Integra LifeSciences Corporation Hemostats Product and Services
       2.8.4 Integra LifeSciences Corporation Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Integra LifeSciences Corporation Recent Developments/Updates
   2.9 B Braun Melsungen AG
       2.9.1 B Braun Melsungen AG Details
       2.9.2 B Braun Melsungen AG Major Business
       2.9.3 B Braun Melsungen AG Hemostats Product and Services
       2.9.4 B Braun Melsungen AG Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 B Braun Melsungen AG Recent Developments/Updates
   2.10 Gelita Medical GmbH
       2.10.1 Gelita Medical GmbH Details
       2.10.2 Gelita Medical GmbH Major Business
       2.10.3 Gelita Medical GmbH Hemostats Product and Services
       2.10.4 Gelita Medical GmbH Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Gelita Medical GmbH Recent Developments/Updates
   2.11 Equimedical
       2.11.1 Equimedical Details
       2.11.2 Equimedical Major Business
       2.11.3 Equimedical Hemostats Product and Services
       2.11.4 Equimedical Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Equimedical Recent Developments/Updates
   2.12 Vascular Solutions
       2.12.1 Vascular Solutions Details
       2.12.2 Vascular Solutions Major Business
       2.12.3 Vascular Solutions Hemostats Product and Services
       2.12.4 Vascular Solutions Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Vascular Solutions Recent Developments/Updates
   2.13 Marine Polymer Technologies
       2.13.1 Marine Polymer Technologies Details
       2.13.2 Marine Polymer Technologies Major Business
       2.13.3 Marine Polymer Technologies Hemostats Product and Services
       2.13.4 Marine Polymer Technologies Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Marine Polymer Technologies Recent Developments/Updates
   2.14 Z-Medica, LLC
       2.14.1 Z-Medica, LLC Details
       2.14.2 Z-Medica, LLC Major Business
       2.14.3 Z-Medica, LLC Hemostats Product and Services
       2.14.4 Z-Medica, LLC Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 Z-Medica, LLC Recent Developments/Updates
   2.15 CryoLife
       2.15.1 CryoLife Details
       2.15.2 CryoLife Major Business
       2.15.3 CryoLife Hemostats Product and Services
       2.15.4 CryoLife Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 CryoLife Recent Developments/Updates
   2.16 BioCer Entwicklungs-GmbH.
       2.16.1 BioCer Entwicklungs-GmbH. Details
       2.16.2 BioCer Entwicklungs-GmbH. Major Business
       2.16.3 BioCer Entwicklungs-GmbH. Hemostats Product and Services
       2.16.4 BioCer Entwicklungs-GmbH. Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.16.5 BioCer Entwicklungs-GmbH. Recent Developments/Updates
   2.17 Biom'Up SAS
       2.17.1 Biom'Up SAS Details
       2.17.2 Biom'Up SAS Major Business
       2.17.3 Biom'Up SAS Hemostats Product and Services
       2.17.4 Biom'Up SAS Hemostats Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.17.5 Biom'Up SAS Recent Developments/Updates

3 Competitive Environment: Hemostats by Manufacturer

   3.1 Global Hemostats Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Hemostats Revenue by Manufacturer (2018-2023)
   3.3 Global Hemostats Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Hemostats by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Hemostats Manufacturer Market Share in 2022
       3.4.2 Top 6 Hemostats Manufacturer Market Share in 2022
   3.5 Hemostats Market: Overall Company Footprint Analysis
       3.5.1 Hemostats Market: Region Footprint
       3.5.2 Hemostats Market: Company Product Type Footprint
       3.5.3 Hemostats Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Hemostats Market Size by Region
       4.1.1 Global Hemostats Sales Quantity by Region (2018-2029)
       4.1.2 Global Hemostats Consumption Value by Region (2018-2029)
       4.1.3 Global Hemostats Average Price by Region (2018-2029)
   4.2 North America Hemostats Consumption Value (2018-2029)
   4.3 Europe Hemostats Consumption Value (2018-2029)
   4.4 Asia-Pacific Hemostats Consumption Value (2018-2029)
   4.5 South America Hemostats Consumption Value (2018-2029)
   4.6 Middle East and Africa Hemostats Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Hemostats Sales Quantity by Type (2018-2029)
   5.2 Global Hemostats Consumption Value by Type (2018-2029)
   5.3 Global Hemostats Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Hemostats Sales Quantity by Application (2018-2029)
   6.2 Global Hemostats Consumption Value by Application (2018-2029)
   6.3 Global Hemostats Average Price by Application (2018-2029)

7 North America

   7.1 North America Hemostats Sales Quantity by Type (2018-2029)
   7.2 North America Hemostats Sales Quantity by Application (2018-2029)
   7.3 North America Hemostats Market Size by Country
       7.3.1 North America Hemostats Sales Quantity by Country (2018-2029)
       7.3.2 North America Hemostats Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Hemostats Sales Quantity by Type (2018-2029)
   8.2 Europe Hemostats Sales Quantity by Application (2018-2029)
   8.3 Europe Hemostats Market Size by Country
       8.3.1 Europe Hemostats Sales Quantity by Country (2018-2029)
       8.3.2 Europe Hemostats Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Hemostats Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Hemostats Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Hemostats Market Size by Region
       9.3.1 Asia-Pacific Hemostats Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Hemostats Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Hemostats Sales Quantity by Type (2018-2029)
   10.2 South America Hemostats Sales Quantity by Application (2018-2029)
   10.3 South America Hemostats Market Size by Country
       10.3.1 South America Hemostats Sales Quantity by Country (2018-2029)
       10.3.2 South America Hemostats Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Hemostats Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Hemostats Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Hemostats Market Size by Country
       11.3.1 Middle East & Africa Hemostats Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Hemostats Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Hemostats Market Drivers
   12.2 Hemostats Market Restraints
   12.3 Hemostats Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Hemostats and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Hemostats
   13.3 Hemostats Production Process
   13.4 Hemostats Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Hemostats Typical Distributors
   14.3 Hemostats Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Hemostats Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Hemostats Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Ethicon Basic Information, Manufacturing Base and Competitors
   Table 4. Ethicon Major Business
   Table 5. Ethicon Hemostats Product and Services
   Table 6. Ethicon Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Ethicon Recent Developments/Updates
   Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
   Table 9. Pfizer Major Business
   Table 10. Pfizer Hemostats Product and Services
   Table 11. Pfizer Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Pfizer Recent Developments/Updates
   Table 13. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
   Table 14. Baxter International Inc. Major Business
   Table 15. Baxter International Inc. Hemostats Product and Services
   Table 16. Baxter International Inc. Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Baxter International Inc. Recent Developments/Updates
   Table 18. C. R. Bard Basic Information, Manufacturing Base and Competitors
   Table 19. C. R. Bard Major Business
   Table 20. C. R. Bard Hemostats Product and Services
   Table 21. C. R. Bard Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. C. R. Bard Recent Developments/Updates
   Table 23. The Medicines Company Basic Information, Manufacturing Base and Competitors
   Table 24. The Medicines Company Major Business
   Table 25. The Medicines Company Hemostats Product and Services
   Table 26. The Medicines Company Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. The Medicines Company Recent Developments/Updates
   Table 28. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
   Table 29. Anika Therapeutics Major Business
   Table 30. Anika Therapeutics Hemostats Product and Services
   Table 31. Anika Therapeutics Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Anika Therapeutics Recent Developments/Updates
   Table 33. Advanced Medical Solutions Basic Information, Manufacturing Base and Competitors
   Table 34. Advanced Medical Solutions Major Business
   Table 35. Advanced Medical Solutions Hemostats Product and Services
   Table 36. Advanced Medical Solutions Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Advanced Medical Solutions Recent Developments/Updates
   Table 38. Integra LifeSciences Corporation Basic Information, Manufacturing Base and Competitors
   Table 39. Integra LifeSciences Corporation Major Business
   Table 40. Integra LifeSciences Corporation Hemostats Product and Services
   Table 41. Integra LifeSciences Corporation Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Integra LifeSciences Corporation Recent Developments/Updates
   Table 43. B Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
   Table 44. B Braun Melsungen AG Major Business
   Table 45. B Braun Melsungen AG Hemostats Product and Services
   Table 46. B Braun Melsungen AG Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. B Braun Melsungen AG Recent Developments/Updates
   Table 48. Gelita Medical GmbH Basic Information, Manufacturing Base and Competitors
   Table 49. Gelita Medical GmbH Major Business
   Table 50. Gelita Medical GmbH Hemostats Product and Services
   Table 51. Gelita Medical GmbH Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Gelita Medical GmbH Recent Developments/Updates
   Table 53. Equimedical Basic Information, Manufacturing Base and Competitors
   Table 54. Equimedical Major Business
   Table 55. Equimedical Hemostats Product and Services
   Table 56. Equimedical Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Equimedical Recent Developments/Updates
   Table 58. Vascular Solutions Basic Information, Manufacturing Base and Competitors
   Table 59. Vascular Solutions Major Business
   Table 60. Vascular Solutions Hemostats Product and Services
   Table 61. Vascular Solutions Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Vascular Solutions Recent Developments/Updates
   Table 63. Marine Polymer Technologies Basic Information, Manufacturing Base and Competitors
   Table 64. Marine Polymer Technologies Major Business
   Table 65. Marine Polymer Technologies Hemostats Product and Services
   Table 66. Marine Polymer Technologies Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 67. Marine Polymer Technologies Recent Developments/Updates
   Table 68. Z-Medica, LLC Basic Information, Manufacturing Base and Competitors
   Table 69. Z-Medica, LLC Major Business
   Table 70. Z-Medica, LLC Hemostats Product and Services
   Table 71. Z-Medica, LLC Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 72. Z-Medica, LLC Recent Developments/Updates
   Table 73. CryoLife Basic Information, Manufacturing Base and Competitors
   Table 74. CryoLife Major Business
   Table 75. CryoLife Hemostats Product and Services
   Table 76. CryoLife Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 77. CryoLife Recent Developments/Updates
   Table 78. BioCer Entwicklungs-GmbH. Basic Information, Manufacturing Base and Competitors
   Table 79. BioCer Entwicklungs-GmbH. Major Business
   Table 80. BioCer Entwicklungs-GmbH. Hemostats Product and Services
   Table 81. BioCer Entwicklungs-GmbH. Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 82. BioCer Entwicklungs-GmbH. Recent Developments/Updates
   Table 83. Biom'Up SAS Basic Information, Manufacturing Base and Competitors
   Table 84. Biom'Up SAS Major Business
   Table 85. Biom'Up SAS Hemostats Product and Services
   Table 86. Biom'Up SAS Hemostats Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 87. Biom'Up SAS Recent Developments/Updates
   Table 88. Global Hemostats Sales Quantity by Manufacturer (2018-2023) & (K Pcs)
   Table 89. Global Hemostats Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 90. Global Hemostats Average Price by Manufacturer (2018-2023) & (USD/Pcs)
   Table 91. Market Position of Manufacturers in Hemostats, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 92. Head Office and Hemostats Production Site of Key Manufacturer
   Table 93. Hemostats Market: Company Product Type Footprint
   Table 94. Hemostats Market: Company Product Application Footprint
   Table 95. Hemostats New Market Entrants and Barriers to Market Entry
   Table 96. Hemostats Mergers, Acquisition, Agreements, and Collaborations
   Table 97. Global Hemostats Sales Quantity by Region (2018-2023) & (K Pcs)
   Table 98. Global Hemostats Sales Quantity by Region (2024-2029) & (K Pcs)
   Table 99. Global Hemostats Consumption Value by Region (2018-2023) & (USD Million)
   Table 100. Global Hemostats Consumption Value by Region (2024-2029) & (USD Million)
   Table 101. Global Hemostats Average Price by Region (2018-2023) & (USD/Pcs)
   Table 102. Global Hemostats Average Price by Region (2024-2029) & (USD/Pcs)
   Table 103. Global Hemostats Sales Quantity by Type (2018-2023) & (K Pcs)
   Table 104. Global Hemostats Sales Quantity by Type (2024-2029) & (K Pcs)
   Table 105. Global Hemostats Consumption Value by Type (2018-2023) & (USD Million)
   Table 106. Global Hemostats Consumption Value by Type (2024-2029) & (USD Million)
   Table 107. Global Hemostats Average Price by Type (2018-2023) & (USD/Pcs)
   Table 108. Global Hemostats Average Price by Type (2024-2029) & (USD/Pcs)
   Table 109. Global Hemostats Sales Quantity by Application (2018-2023) & (K Pcs)
   Table 110. Global Hemostats Sales Quantity by Application (2024-2029) & (K Pcs)
   Table 111. Global Hemostats Consumption Value by Application (2018-2023) & (USD Million)
   Table 112. Global Hemostats Consumption Value by Application (2024-2029) & (USD Million)
   Table 113. Global Hemostats Average Price by Application (2018-2023) & (USD/Pcs)
   Table 114. Global Hemostats Average Price by Application (2024-2029) & (USD/Pcs)
   Table 115. North America Hemostats Sales Quantity by Type (2018-2023) & (K Pcs)
   Table 116. North America Hemostats Sales Quantity by Type (2024-2029) & (K Pcs)
   Table 117. North America Hemostats Sales Quantity by Application (2018-2023) & (K Pcs)
   Table 118. North America Hemostats Sales Quantity by Application (2024-2029) & (K Pcs)
   Table 119. North America Hemostats Sales Quantity by Country (2018-2023) & (K Pcs)
   Table 120. North America Hemostats Sales Quantity by Country (2024-2029) & (K Pcs)
   Table 121. North America Hemostats Consumption Value by Country (2018-2023) & (USD Million)
   Table 122. North America Hemostats Consumption Value by Country (2024-2029) & (USD Million)
   Table 123. Europe Hemostats Sales Quantity by Type (2018-2023) & (K Pcs)
   Table 124. Europe Hemostats Sales Quantity by Type (2024-2029) & (K Pcs)
   Table 125. Europe Hemostats Sales Quantity by Application (2018-2023) & (K Pcs)
   Table 126. Europe Hemostats Sales Quantity by Application (2024-2029) & (K Pcs)
   Table 127. Europe Hemostats Sales Quantity by Country (2018-2023) & (K Pcs)
   Table 128. Europe Hemostats Sales Quantity by Country (2024-2029) & (K Pcs)
   Table 129. Europe Hemostats Consumption Value by Country (2018-2023) & (USD Million)
   Table 130. Europe Hemostats Consumption Value by Country (2024-2029) & (USD Million)
   Table 131. Asia-Pacific Hemostats Sales Quantity by Type (2018-2023) & (K Pcs)
   Table 132. Asia-Pacific Hemostats Sales Quantity by Type (2024-2029) & (K Pcs)
   Table 133. Asia-Pacific Hemostats Sales Quantity by Application (2018-2023) & (K Pcs)
   Table 134. Asia-Pacific Hemostats Sales Quantity by Application (2024-2029) & (K Pcs)
   Table 135. Asia-Pacific Hemostats Sales Quantity by Region (2018-2023) & (K Pcs)
   Table 136. Asia-Pacific Hemostats Sales Quantity by Region (2024-2029) & (K Pcs)
   Table 137. Asia-Pacific Hemostats Consumption Value by Region (2018-2023) & (USD Million)
   Table 138. Asia-Pacific Hemostats Consumption Value by Region (2024-2029) & (USD Million)
   Table 139. South America Hemostats Sales Quantity by Type (2018-2023) & (K Pcs)
   Table 140. South America Hemostats Sales Quantity by Type (2024-2029) & (K Pcs)
   Table 141. South America Hemostats Sales Quantity by Application (2018-2023) & (K Pcs)
   Table 142. South America Hemostats Sales Quantity by Application (2024-2029) & (K Pcs)
   Table 143. South America Hemostats Sales Quantity by Country (2018-2023) & (K Pcs)
   Table 144. South America Hemostats Sales Quantity by Country (2024-2029) & (K Pcs)
   Table 145. South America Hemostats Consumption Value by Country (2018-2023) & (USD Million)
   Table 146. South America Hemostats Consumption Value by Country (2024-2029) & (USD Million)
   Table 147. Middle East & Africa Hemostats Sales Quantity by Type (2018-2023) & (K Pcs)
   Table 148. Middle East & Africa Hemostats Sales Quantity by Type (2024-2029) & (K Pcs)
   Table 149. Middle East & Africa Hemostats Sales Quantity by Application (2018-2023) & (K Pcs)
   Table 150. Middle East & Africa Hemostats Sales Quantity by Application (2024-2029) & (K Pcs)
   Table 151. Middle East & Africa Hemostats Sales Quantity by Region (2018-2023) & (K Pcs)
   Table 152. Middle East & Africa Hemostats Sales Quantity by Region (2024-2029) & (K Pcs)
   Table 153. Middle East & Africa Hemostats Consumption Value by Region (2018-2023) & (USD Million)
   Table 154. Middle East & Africa Hemostats Consumption Value by Region (2024-2029) & (USD Million)
   Table 155. Hemostats Raw Material
   Table 156. Key Manufacturers of Hemostats Raw Materials
   Table 157. Hemostats Typical Distributors
   Table 158. Hemostats Typical Customers

List of Figures

   Figure 1. Hemostats Picture
   Figure 2. Global Hemostats Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Hemostats Consumption Value Market Share by Type in 2022
   Figure 4. Thrombin-Based Hemostats Examples
   Figure 5. Oxidized Regenerated Cellulose Based Hemostats Examples
   Figure 6. Combination Hemostats Examples
   Figure 7. Gelatin Based Hemostats Examples
   Figure 8. Collagen Based Hemostats Examples
   Figure 9. Global Hemostats Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 10. Global Hemostats Consumption Value Market Share by Application in 2022
   Figure 11. Prehospital Treatment Examples
   Figure 12. Hospital Treatment Examples
   Figure 13. Global Hemostats Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 14. Global Hemostats Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 15. Global Hemostats Sales Quantity (2018-2029) & (K Pcs)
   Figure 16. Global Hemostats Average Price (2018-2029) & (USD/Pcs)
   Figure 17. Global Hemostats Sales Quantity Market Share by Manufacturer in 2022
   Figure 18. Global Hemostats Consumption Value Market Share by Manufacturer in 2022
   Figure 19. Producer Shipments of Hemostats by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 20. Top 3 Hemostats Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Top 6 Hemostats Manufacturer (Consumption Value) Market Share in 2022
   Figure 22. Global Hemostats Sales Quantity Market Share by Region (2018-2029)
   Figure 23. Global Hemostats Consumption Value Market Share by Region (2018-2029)
   Figure 24. North America Hemostats Consumption Value (2018-2029) & (USD Million)
   Figure 25. Europe Hemostats Consumption Value (2018-2029) & (USD Million)
   Figure 26. Asia-Pacific Hemostats Consumption Value (2018-2029) & (USD Million)
   Figure 27. South America Hemostats Consumption Value (2018-2029) & (USD Million)
   Figure 28. Middle East & Africa Hemostats Consumption Value (2018-2029) & (USD Million)
   Figure 29. Global Hemostats Sales Quantity Market Share by Type (2018-2029)
   Figure 30. Global Hemostats Consumption Value Market Share by Type (2018-2029)
   Figure 31. Global Hemostats Average Price by Type (2018-2029) & (USD/Pcs)
   Figure 32. Global Hemostats Sales Quantity Market Share by Application (2018-2029)
   Figure 33. Global Hemostats Consumption Value Market Share by Application (2018-2029)
   Figure 34. Global Hemostats Average Price by Application (2018-2029) & (USD/Pcs)
   Figure 35. North America Hemostats Sales Quantity Market Share by Type (2018-2029)
   Figure 36. North America Hemostats Sales Quantity Market Share by Application (2018-2029)
   Figure 37. North America Hemostats Sales Quantity Market Share by Country (2018-2029)
   Figure 38. North America Hemostats Consumption Value Market Share by Country (2018-2029)
   Figure 39. United States Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Canada Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Mexico Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 42. Europe Hemostats Sales Quantity Market Share by Type (2018-2029)
   Figure 43. Europe Hemostats Sales Quantity Market Share by Application (2018-2029)
   Figure 44. Europe Hemostats Sales Quantity Market Share by Country (2018-2029)
   Figure 45. Europe Hemostats Consumption Value Market Share by Country (2018-2029)
   Figure 46. Germany Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. France Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. United Kingdom Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Russia Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Italy Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 51. Asia-Pacific Hemostats Sales Quantity Market Share by Type (2018-2029)
   Figure 52. Asia-Pacific Hemostats Sales Quantity Market Share by Application (2018-2029)
   Figure 53. Asia-Pacific Hemostats Sales Quantity Market Share by Region (2018-2029)
   Figure 54. Asia-Pacific Hemostats Consumption Value Market Share by Region (2018-2029)
   Figure 55. China Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Japan Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Korea Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. India Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Southeast Asia Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. Australia Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 61. South America Hemostats Sales Quantity Market Share by Type (2018-2029)
   Figure 62. South America Hemostats Sales Quantity Market Share by Application (2018-2029)
   Figure 63. South America Hemostats Sales Quantity Market Share by Country (2018-2029)
   Figure 64. South America Hemostats Consumption Value Market Share by Country (2018-2029)
   Figure 65. Brazil Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Argentina Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 67. Middle East & Africa Hemostats Sales Quantity Market Share by Type (2018-2029)
   Figure 68. Middle East & Africa Hemostats Sales Quantity Market Share by Application (2018-2029)
   Figure 69. Middle East & Africa Hemostats Sales Quantity Market Share by Region (2018-2029)
   Figure 70. Middle East & Africa Hemostats Consumption Value Market Share by Region (2018-2029)
   Figure 71. Turkey Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Egypt Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Saudi Arabia Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. South Africa Hemostats Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 75. Hemostats Market Drivers
   Figure 76. Hemostats Market Restraints
   Figure 77. Hemostats Market Trends
   Figure 78. Porters Five Forces Analysis
   Figure 79. Manufacturing Cost Structure Analysis of Hemostats in 2022
   Figure 80. Manufacturing Process Analysis of Hemostats
   Figure 81. Hemostats Industrial Chain
   Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 83. Direct Channel Pros & Cons
   Figure 84. Indirect Channel Pros & Cons
   Figure 85. Methodology
   Figure 86. Research Process and Data Source